MITO
Stealth BioTherapeutics Corp. ADS
MITO
MITO
Delisted
MITO was delisted on the 15th of November, 2022.
13 hedge funds and large institutions have $638K invested in Stealth BioTherapeutics Corp. ADS in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$17.8K | |
| 2 | +$16.2K | |
| 3 | +$4K | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$1.27K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.13K |
Top Sellers
| 1 | -$16K | |
| 2 | -$13K | |
| 3 | -$7.39K | |
| 4 |
Two Sigma Advisers
New York
|
-$5.9K |
| 5 |
Millennium Management
New York
|
-$1.08K |